Back to News
Market Impact: 0.3

Palantir Technologies Stock Could Soar 55% in 1 Year, According to Wall Street. Should You Buy It Hand Over Fist?

+1
Artificial IntelligenceCompany FundamentalsAnalyst EstimatesCorporate Guidance & OutlookInvestor Sentiment & Positioning

Palantir shares have fallen ~37% from the 52-week high, but Wall Street is looking for a rebound with a median 12-month price target of $200 (about +55% upside) from current levels. Consensus EPS is expected to rise 97% in 2026 to $1.48, after Q1 EPS grew 154% YoY, with 2026 guidance raised. Growth indicators also strengthened: customer count +31% in Q1, total contract value $2.41B (+61% YoY), and remaining deal value $11.8B (nearly double), supporting expectations of sustained high earnings growth.

Analysis

PLTR is still being treated as a momentum asset, not a fundamentals compounder, so the stock will likely trade off changes in growth durability rather than current growth itself. The key second-order issue is that once a premium software name gets re-rated, even strong execution can look “not good enough” if the market expects accelerating adoption every quarter; that creates a fragile multiple where any hint of slowing net-new customer wins can trigger another leg down.

The more interesting competitive angle is that the market is no longer asking whether AI works, but which vendor captures enterprise budgets at acceptable cost. That favors incumbents with existing procurement relationships and broader suites, such as SAP, and it also means PLTR’s moat must show up in retention and expansion, not just pilot conversions. If AI tooling commoditizes faster than expected, the valuation gap between pure-play platforms and large-cap software could narrow sharply even if end-demand remains healthy.

Near term, the stock can squeeze higher on any print that validates backlog conversion and margin discipline, because positioning is likely lighter after the drawdown. Over 6-18 months, though, the burden of proof is on sustaining high growth off a much larger base; if growth normalizes faster than consensus, the multiple can compress even with positive EPS revisions. The contrarian point: the street may be underweighting how much of the upside is already in the price target math, so PLTR likely needs an upside revision cycle, not just “good results,” to outperform meaningfully.

More News